Equities analysts expect Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to post $94.05 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for Ironwood Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $93.50 million and the highest estimate coming in at $94.60 million. Ironwood Pharmaceuticals posted sales of $89.43 million […]
